Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1384489 (
Scratch
)
395
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
protein tyrosine phosphatase 1B
(
PTP1B
) is an important regulator of metabolism. The relationship between
PTP1B
and tumors is quite complex. The purpose of this study is to explore the expression pattern and role of
PTP1B
in breast cancer. The expression of
PTP1B
was detected in 67 samples of breast cancer tissue by Western blot. Cell growth assay, Transwell migration assay, and
Scratch
motility assay were used to examine the proliferation and migration of MCF-7 with and without
PTP1B
. The total levels and phosphorylated levels of signal transduction and activator of transcription 3 (STAT3) and the expression of C-C motif chemokine ligand 5 (CCL5) were also examined by Western blot.
PTP1B
was overexpressed in over 70% of breast cancer tissues, correlating with patients with estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and human epidermal growth factor receptor 2 (HER2)-positive tumors. The data also showed that both tumor size and lymph node metastasis were significantly higher in patients with a higher level of
PTP1B
. The proliferation and migration of MCF-7 cells were found to be inhibited after knocking down the gene of
PTP1B
. Our data also showed that
PTP1B
could up-regulate the dephosphorylated level of STAT3, which could increase the expression of CCL5. These phenomena indicated that
PTP1B
may play a crucial role in the development of breast cancer.
...
PMID:Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer. 2837 71